nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—NTRK1—Amitriptyline—migraine	0.291	0.416	CbGbCtD
Regorafenib—UGT1A9—Valproic Acid—migraine	0.0668	0.0955	CbGbCtD
Regorafenib—ABCG2—Verapamil—migraine	0.0262	0.0374	CbGbCtD
Regorafenib—CYP2B6—Amitriptyline—migraine	0.0232	0.0332	CbGbCtD
Regorafenib—CYP2B6—Valproic Acid—migraine	0.0211	0.0302	CbGbCtD
Regorafenib—CYP2C19—Timolol—migraine	0.0191	0.0273	CbGbCtD
Regorafenib—CYP2B6—Verapamil—migraine	0.0184	0.0263	CbGbCtD
Regorafenib—CYP2C8—Amitriptyline—migraine	0.0176	0.0251	CbGbCtD
Regorafenib—CYP2C19—Propranolol—migraine	0.017	0.0244	CbGbCtD
Regorafenib—CYP2C8—Valproic Acid—migraine	0.016	0.0229	CbGbCtD
Regorafenib—ABCB1—Timolol—migraine	0.0154	0.0221	CbGbCtD
Regorafenib—CYP2C19—Amitriptyline—migraine	0.0147	0.0211	CbGbCtD
Regorafenib—CYP2C8—Verapamil—migraine	0.0139	0.0199	CbGbCtD
Regorafenib—ABCB1—Propranolol—migraine	0.0138	0.0197	CbGbCtD
Regorafenib—CYP2C19—Valproic Acid—migraine	0.0134	0.0192	CbGbCtD
Regorafenib—CYP2C9—Amitriptyline—migraine	0.0123	0.0175	CbGbCtD
Regorafenib—CYP2C19—Topiramate—migraine	0.0121	0.0173	CbGbCtD
Regorafenib—ABCB1—Amitriptyline—migraine	0.0119	0.017	CbGbCtD
Regorafenib—CYP2C19—Verapamil—migraine	0.0117	0.0167	CbGbCtD
Regorafenib—CYP2C9—Valproic Acid—migraine	0.0112	0.016	CbGbCtD
Regorafenib—CYP2C9—Verapamil—migraine	0.00973	0.0139	CbGbCtD
Regorafenib—ABCB1—Verapamil—migraine	0.00944	0.0135	CbGbCtD
Regorafenib—CYP3A4—Propranolol—migraine	0.00824	0.0118	CbGbCtD
Regorafenib—CYP3A4—Amitriptyline—migraine	0.00713	0.0102	CbGbCtD
Regorafenib—CYP3A4—Valproic Acid—migraine	0.0065	0.00929	CbGbCtD
Regorafenib—CYP3A4—Topiramate—migraine	0.00586	0.00838	CbGbCtD
Regorafenib—CYP3A4—Verapamil—migraine	0.00566	0.00808	CbGbCtD
Regorafenib—FGFR2—skull—migraine	0.00428	0.0469	CbGeAlD
Regorafenib—RET—autonomic nervous system—migraine	0.00422	0.0462	CbGeAlD
Regorafenib—Sorafenib—HTR2B—migraine	0.00368	0.672	CrCbGaD
Regorafenib—NTRK1—trigeminal ganglion—migraine	0.00288	0.0316	CbGeAlD
Regorafenib—Traumatic liver injury—Valproic Acid—migraine	0.00263	0.022	CcSEcCtD
Regorafenib—FLT4—blood vessel—migraine	0.00211	0.0231	CbGeAlD
Regorafenib—Amylase increased—Valproic Acid—migraine	0.00206	0.0172	CcSEcCtD
Regorafenib—Sorafenib—HTR2C—migraine	0.0018	0.328	CrCbGaD
Regorafenib—Hepatotoxicity—Verapamil—migraine	0.00179	0.015	CcSEcCtD
Regorafenib—EPHA2—blood vessel—migraine	0.00174	0.0191	CbGeAlD
Regorafenib—TEK—blood vessel—migraine	0.0017	0.0186	CbGeAlD
Regorafenib—FLT1—blood vessel—migraine	0.00164	0.018	CbGeAlD
Regorafenib—Polyp—Valproic Acid—migraine	0.00161	0.0135	CcSEcCtD
Regorafenib—DDR2—cardiovascular system—migraine	0.00155	0.0169	CbGeAlD
Regorafenib—Hypothyroidism—Valproic Acid—migraine	0.00153	0.0128	CcSEcCtD
Regorafenib—Mucosal inflammation—Gabapentin—migraine	0.00147	0.0123	CcSEcCtD
Regorafenib—Cyst—Valproic Acid—migraine	0.00147	0.0123	CcSEcCtD
Regorafenib—KDR—blood vessel—migraine	0.00139	0.0152	CbGeAlD
Regorafenib—Lymphopenia—Topiramate—migraine	0.00134	0.0112	CcSEcCtD
Regorafenib—RET—neck—migraine	0.00133	0.0146	CbGeAlD
Regorafenib—FGFR1—trigeminal ganglion—migraine	0.00129	0.0141	CbGeAlD
Regorafenib—Hepatotoxicity—Valproic Acid—migraine	0.00127	0.0106	CcSEcCtD
Regorafenib—FGFR2—neck—migraine	0.00127	0.0139	CbGeAlD
Regorafenib—Hypothyroidism—Gabapentin—migraine	0.00127	0.0106	CcSEcCtD
Regorafenib—Nail disorder—Gabapentin—migraine	0.00125	0.0105	CcSEcCtD
Regorafenib—KIT—blood vessel—migraine	0.00123	0.0135	CbGeAlD
Regorafenib—PDGFRB—blood vessel—migraine	0.0012	0.0132	CbGeAlD
Regorafenib—Endocrine disorder—Valproic Acid—migraine	0.00118	0.00988	CcSEcCtD
Regorafenib—Hypophosphataemia—Topiramate—migraine	0.00118	0.00983	CcSEcCtD
Regorafenib—FLT1—neck—migraine	0.00118	0.0129	CbGeAlD
Regorafenib—RAF1—neck—migraine	0.00117	0.0128	CbGeAlD
Regorafenib—Liver injury—Valproic Acid—migraine	0.00117	0.00973	CcSEcCtD
Regorafenib—RET—trigeminal ganglion—migraine	0.00115	0.0126	CbGeAlD
Regorafenib—Musculoskeletal stiffness—Valproic Acid—migraine	0.00109	0.00913	CcSEcCtD
Regorafenib—EPHA2—trigeminal ganglion—migraine	0.00108	0.0118	CbGeAlD
Regorafenib—Nail disorder—Topiramate—migraine	0.00106	0.00881	CcSEcCtD
Regorafenib—TEK—trigeminal ganglion—migraine	0.00105	0.0115	CbGeAlD
Regorafenib—DDR2—head—migraine	0.00105	0.0115	CbGeAlD
Regorafenib—Acute coronary syndrome—Amitriptyline—migraine	0.00102	0.0085	CcSEcCtD
Regorafenib—FLT1—trigeminal ganglion—migraine	0.00101	0.0111	CbGeAlD
Regorafenib—Myocardial infarction—Amitriptyline—migraine	0.00101	0.00846	CcSEcCtD
Regorafenib—RAF1—trigeminal ganglion—migraine	0.00101	0.011	CbGeAlD
Regorafenib—Stomatitis—Amitriptyline—migraine	0.00101	0.00841	CcSEcCtD
Regorafenib—KDR—neck—migraine	0.000993	0.0109	CbGeAlD
Regorafenib—DDR2—nervous system—migraine	0.000993	0.0109	CbGeAlD
Regorafenib—MAPK11—head—migraine	0.000993	0.0109	CbGeAlD
Regorafenib—Dysphonia—Gabapentin—migraine	0.000989	0.00825	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Propranolol—migraine	0.000983	0.00821	CcSEcCtD
Regorafenib—FGFR2—brainstem—migraine	0.000969	0.0106	CbGeAlD
Regorafenib—DDR2—central nervous system—migraine	0.000956	0.0105	CbGeAlD
Regorafenib—FLT4—cardiovascular system—migraine	0.000943	0.0103	CbGeAlD
Regorafenib—MAPK11—nervous system—migraine	0.000942	0.0103	CbGeAlD
Regorafenib—DDR2—cerebellum—migraine	0.000935	0.0102	CbGeAlD
Regorafenib—MAPK11—central nervous system—migraine	0.000907	0.00993	CbGeAlD
Regorafenib—RAF1—brainstem—migraine	0.000893	0.00978	CbGeAlD
Regorafenib—Neoplasm—Valproic Acid—migraine	0.000887	0.0074	CcSEcCtD
Regorafenib—MAPK11—cerebellum—migraine	0.000886	0.0097	CbGeAlD
Regorafenib—Neutropenia—Propranolol—migraine	0.000883	0.00737	CcSEcCtD
Regorafenib—KIT—neck—migraine	0.00088	0.00964	CbGeAlD
Regorafenib—PDGFRB—neck—migraine	0.00086	0.00942	CbGeAlD
Regorafenib—KDR—trigeminal ganglion—migraine	0.000858	0.00939	CbGeAlD
Regorafenib—Infestation NOS—Propranolol—migraine	0.000842	0.00702	CcSEcCtD
Regorafenib—Infestation—Propranolol—migraine	0.000842	0.00702	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Propranolol—migraine	0.000834	0.00696	CcSEcCtD
Regorafenib—Dysphonia—Topiramate—migraine	0.000832	0.00694	CcSEcCtD
Regorafenib—Endocrine disorder—Topiramate—migraine	0.000826	0.00689	CcSEcCtD
Regorafenib—Alopecia—Amitriptyline—migraine	0.00082	0.00684	CcSEcCtD
Regorafenib—Gastroenteritis—Valproic Acid—migraine	0.000804	0.00671	CcSEcCtD
Regorafenib—FGFR2—cardiovascular system—migraine	0.000791	0.00866	CbGeAlD
Regorafenib—EPHA2—cardiovascular system—migraine	0.000777	0.00851	CbGeAlD
Regorafenib—Stevens-Johnson syndrome—Verapamil—migraine	0.000768	0.00641	CcSEcCtD
Regorafenib—Acute coronary syndrome—Verapamil—migraine	0.000763	0.00637	CcSEcCtD
Regorafenib—Musculoskeletal stiffness—Topiramate—migraine	0.000763	0.00637	CcSEcCtD
Regorafenib—KIT—trigeminal ganglion—migraine	0.00076	0.00832	CbGeAlD
Regorafenib—DDR2—brain—migraine	0.000759	0.00831	CbGeAlD
Regorafenib—Myocardial infarction—Verapamil—migraine	0.000759	0.00633	CcSEcCtD
Regorafenib—TEK—cardiovascular system—migraine	0.000758	0.0083	CbGeAlD
Regorafenib—Gastrooesophageal reflux disease—Topiramate—migraine	0.000758	0.00632	CcSEcCtD
Regorafenib—Tremor—Amitriptyline—migraine	0.000757	0.00632	CcSEcCtD
Regorafenib—Hypocalcaemia—Topiramate—migraine	0.000748	0.00624	CcSEcCtD
Regorafenib—PDGFRB—trigeminal ganglion—migraine	0.000742	0.00813	CbGeAlD
Regorafenib—FLT1—cardiovascular system—migraine	0.000733	0.00802	CbGeAlD
Regorafenib—RAF1—cardiovascular system—migraine	0.000729	0.00798	CbGeAlD
Regorafenib—Leukopenia—Amitriptyline—migraine	0.000723	0.00603	CcSEcCtD
Regorafenib—MAPK11—brain—migraine	0.00072	0.00788	CbGeAlD
Regorafenib—Hyponatraemia—Valproic Acid—migraine	0.000715	0.00597	CcSEcCtD
Regorafenib—Erythema multiforme—Propranolol—migraine	0.000714	0.00596	CcSEcCtD
Regorafenib—Cardiac disorder—Propranolol—migraine	0.000701	0.00585	CcSEcCtD
Regorafenib—Hypertension—Amitriptyline—migraine	0.000697	0.00582	CcSEcCtD
Regorafenib—PDGFRA—cardiovascular system—migraine	0.000687	0.00752	CbGeAlD
Regorafenib—KIT—brainstem—migraine	0.000673	0.00737	CbGeAlD
Regorafenib—Dry mouth—Amitriptyline—migraine	0.000673	0.00561	CcSEcCtD
Regorafenib—Alopecia—Propranolol—migraine	0.000668	0.00557	CcSEcCtD
Regorafenib—Gastroenteritis—Gabapentin—migraine	0.000666	0.00556	CcSEcCtD
Regorafenib—ABL1—trigeminal ganglion—migraine	0.000662	0.00725	CbGeAlD
Regorafenib—BRAF—cerebellum—migraine	0.000661	0.00723	CbGeAlD
Regorafenib—Erythema multiforme—Verapamil—migraine	0.000657	0.00548	CcSEcCtD
Regorafenib—Dry skin—Valproic Acid—migraine	0.000653	0.00545	CcSEcCtD
Regorafenib—Thrombocytopenia—Amitriptyline—migraine	0.000645	0.00539	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Valproic Acid—migraine	0.000641	0.00535	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Valproic Acid—migraine	0.000641	0.00535	CcSEcCtD
Regorafenib—FLT4—head—migraine	0.000638	0.00699	CbGeAlD
Regorafenib—EPHX2—cerebellum—migraine	0.000631	0.00691	CbGeAlD
Regorafenib—Alanine aminotransferase increased—Valproic Acid—migraine	0.000628	0.00524	CcSEcCtD
Regorafenib—KDR—cardiovascular system—migraine	0.00062	0.00678	CbGeAlD
Regorafenib—Neoplasm—Topiramate—migraine	0.000619	0.00516	CcSEcCtD
Regorafenib—Alopecia—Verapamil—migraine	0.000614	0.00513	CcSEcCtD
Regorafenib—Hyponatraemia—Gabapentin—migraine	0.000593	0.00495	CcSEcCtD
Regorafenib—ABL1—brainstem—migraine	0.000586	0.00641	CbGeAlD
Regorafenib—Neutropenia—Valproic Acid—migraine	0.000576	0.0048	CcSEcCtD
Regorafenib—Decreased appetite—Amitriptyline—migraine	0.000573	0.00478	CcSEcCtD
Regorafenib—Fatigue—Amitriptyline—migraine	0.000568	0.00474	CcSEcCtD
Regorafenib—Tremor—Verapamil—migraine	0.000567	0.00473	CcSEcCtD
Regorafenib—RET—head—migraine	0.000563	0.00617	CbGeAlD
Regorafenib—FGFR1—cerebellum—migraine	0.000562	0.00615	CbGeAlD
Regorafenib—Gastroenteritis—Topiramate—migraine	0.00056	0.00468	CcSEcCtD
Regorafenib—Weight decreased—Valproic Acid—migraine	0.000557	0.00465	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000556	0.00464	CcSEcCtD
Regorafenib—KIT—cardiovascular system—migraine	0.000549	0.00601	CbGeAlD
Regorafenib—Stevens-Johnson syndrome—Valproic Acid—migraine	0.000544	0.00454	CcSEcCtD
Regorafenib—Dry skin—Gabapentin—migraine	0.000541	0.00452	CcSEcCtD
Regorafenib—BRAF—brain—migraine	0.000537	0.00588	CbGeAlD
Regorafenib—PDGFRB—cardiovascular system—migraine	0.000536	0.00587	CbGeAlD
Regorafenib—FGFR2—head—migraine	0.000535	0.00586	CbGeAlD
Regorafenib—Stomatitis—Valproic Acid—migraine	0.000535	0.00447	CcSEcCtD
Regorafenib—RET—nervous system—migraine	0.000534	0.00585	CbGeAlD
Regorafenib—Infection—Propranolol—migraine	0.000533	0.00445	CcSEcCtD
Regorafenib—Nervous system disorder—Propranolol—migraine	0.000526	0.00439	CcSEcCtD
Regorafenib—EPHA2—head—migraine	0.000526	0.00576	CbGeAlD
Regorafenib—Hypertension—Verapamil—migraine	0.000522	0.00436	CcSEcCtD
Regorafenib—Skin disorder—Propranolol—migraine	0.000521	0.00435	CcSEcCtD
Regorafenib—Body temperature increased—Amitriptyline—migraine	0.000521	0.00435	CcSEcCtD
Regorafenib—Hepatobiliary disease—Valproic Acid—migraine	0.000519	0.00433	CcSEcCtD
Regorafenib—RET—central nervous system—migraine	0.000514	0.00563	CbGeAlD
Regorafenib—TEK—head—migraine	0.000513	0.00562	CbGeAlD
Regorafenib—EPHX2—brain—migraine	0.000513	0.00562	CbGeAlD
Regorafenib—FGFR2—nervous system—migraine	0.000508	0.00556	CbGeAlD
Regorafenib—Dry mouth—Verapamil—migraine	0.000504	0.0042	CcSEcCtD
Regorafenib—RET—cerebellum—migraine	0.000503	0.0055	CbGeAlD
Regorafenib—EPHA2—nervous system—migraine	0.000499	0.00546	CbGeAlD
Regorafenib—Hyponatraemia—Topiramate—migraine	0.000499	0.00416	CcSEcCtD
Regorafenib—FLT1—head—migraine	0.000496	0.00543	CbGeAlD
Regorafenib—Weight decreased—Timolol—migraine	0.000496	0.00414	CcSEcCtD
Regorafenib—Haemoglobin—Valproic Acid—migraine	0.000495	0.00413	CcSEcCtD
Regorafenib—RAF1—head—migraine	0.000493	0.0054	CbGeAlD
Regorafenib—Haemorrhage—Valproic Acid—migraine	0.000493	0.00411	CcSEcCtD
Regorafenib—Infection—Verapamil—migraine	0.000491	0.00409	CcSEcCtD
Regorafenib—FGFR2—central nervous system—migraine	0.000489	0.00535	CbGeAlD
Regorafenib—TEK—nervous system—migraine	0.000487	0.00533	CbGeAlD
Regorafenib—Urinary tract disorder—Valproic Acid—migraine	0.000487	0.00406	CcSEcCtD
Regorafenib—Connective tissue disorder—Valproic Acid—migraine	0.000484	0.00404	CcSEcCtD
Regorafenib—Urethral disorder—Valproic Acid—migraine	0.000483	0.00403	CcSEcCtD
Regorafenib—EPHA2—central nervous system—migraine	0.00048	0.00526	CbGeAlD
Regorafenib—ABL1—cardiovascular system—migraine	0.000478	0.00523	CbGeAlD
Regorafenib—FGFR2—cerebellum—migraine	0.000478	0.00523	CbGeAlD
Regorafenib—Asthenia—Amitriptyline—migraine	0.000473	0.00395	CcSEcCtD
Regorafenib—FLT1—nervous system—migraine	0.000471	0.00515	CbGeAlD
Regorafenib—TEK—central nervous system—migraine	0.000469	0.00513	CbGeAlD
Regorafenib—RAF1—nervous system—migraine	0.000468	0.00512	CbGeAlD
Regorafenib—Decreased appetite—Propranolol—migraine	0.000467	0.00389	CcSEcCtD
Regorafenib—Erythema multiforme—Valproic Acid—migraine	0.000466	0.00389	CcSEcCtD
Regorafenib—PDGFRA—head—migraine	0.000465	0.00509	CbGeAlD
Regorafenib—Gastrointestinal disorder—Propranolol—migraine	0.000463	0.00387	CcSEcCtD
Regorafenib—Fatigue—Propranolol—migraine	0.000463	0.00386	CcSEcCtD
Regorafenib—FLT4—brain—migraine	0.000463	0.00506	CbGeAlD
Regorafenib—Weight decreased—Gabapentin—migraine	0.000462	0.00385	CcSEcCtD
Regorafenib—Pain—Propranolol—migraine	0.000459	0.00383	CcSEcCtD
Regorafenib—TEK—cerebellum—migraine	0.000458	0.00501	CbGeAlD
Regorafenib—FGFR1—brain—migraine	0.000456	0.005	CbGeAlD
Regorafenib—Infestation NOS—Gabapentin—migraine	0.000455	0.0038	CcSEcCtD
Regorafenib—Infestation—Gabapentin—migraine	0.000455	0.0038	CcSEcCtD
Regorafenib—FLT1—central nervous system—migraine	0.000453	0.00496	CbGeAlD
Regorafenib—Hypokalaemia—Topiramate—migraine	0.000452	0.00377	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Gabapentin—migraine	0.000451	0.00377	CcSEcCtD
Regorafenib—Diarrhoea—Amitriptyline—migraine	0.000451	0.00376	CcSEcCtD
Regorafenib—RAF1—central nervous system—migraine	0.00045	0.00493	CbGeAlD
Regorafenib—Acute coronary syndrome—Gabapentin—migraine	0.000449	0.00374	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Topiramate—migraine	0.000447	0.00373	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Topiramate—migraine	0.000447	0.00373	CcSEcCtD
Regorafenib—Angiopathy—Valproic Acid—migraine	0.000447	0.00373	CcSEcCtD
Regorafenib—Myocardial infarction—Gabapentin—migraine	0.000446	0.00372	CcSEcCtD
Regorafenib—Mediastinal disorder—Valproic Acid—migraine	0.000444	0.00371	CcSEcCtD
Regorafenib—Stomatitis—Gabapentin—migraine	0.000444	0.0037	CcSEcCtD
Regorafenib—FLT1—cerebellum—migraine	0.000443	0.00485	CbGeAlD
Regorafenib—PDGFRA—nervous system—migraine	0.000441	0.00483	CbGeAlD
Regorafenib—RAF1—cerebellum—migraine	0.00044	0.00482	CbGeAlD
Regorafenib—Gastrointestinal pain—Propranolol—migraine	0.000439	0.00366	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Topiramate—migraine	0.000438	0.00366	CcSEcCtD
Regorafenib—Alopecia—Valproic Acid—migraine	0.000435	0.00363	CcSEcCtD
Regorafenib—Connective tissue disorder—Timolol—migraine	0.000431	0.0036	CcSEcCtD
Regorafenib—Hepatobiliary disease—Gabapentin—migraine	0.00043	0.00359	CcSEcCtD
Regorafenib—Malnutrition—Valproic Acid—migraine	0.000429	0.00358	CcSEcCtD
Regorafenib—Fatigue—Verapamil—migraine	0.000426	0.00355	CcSEcCtD
Regorafenib—PDGFRA—central nervous system—migraine	0.000424	0.00465	CbGeAlD
Regorafenib—Abdominal pain—Propranolol—migraine	0.000424	0.00354	CcSEcCtD
Regorafenib—Body temperature increased—Propranolol—migraine	0.000424	0.00354	CcSEcCtD
Regorafenib—Pain—Verapamil—migraine	0.000422	0.00352	CcSEcCtD
Regorafenib—KDR—head—migraine	0.00042	0.00459	CbGeAlD
Regorafenib—Vomiting—Amitriptyline—migraine	0.000419	0.0035	CcSEcCtD
Regorafenib—ABCG2—trigeminal ganglion—migraine	0.000417	0.00457	CbGeAlD
Regorafenib—Rash—Amitriptyline—migraine	0.000416	0.00347	CcSEcCtD
Regorafenib—Dermatitis—Amitriptyline—migraine	0.000415	0.00347	CcSEcCtD
Regorafenib—PDGFRA—cerebellum—migraine	0.000415	0.00454	CbGeAlD
Regorafenib—Headache—Amitriptyline—migraine	0.000413	0.00345	CcSEcCtD
Regorafenib—Haemorrhage—Gabapentin—migraine	0.000408	0.00341	CcSEcCtD
Regorafenib—RET—brain—migraine	0.000408	0.00447	CbGeAlD
Regorafenib—Cardiac disorder—Timolol—migraine	0.000407	0.0034	CcSEcCtD
Regorafenib—Urinary tract disorder—Gabapentin—migraine	0.000403	0.00337	CcSEcCtD
Regorafenib—Tremor—Valproic Acid—migraine	0.000402	0.00335	CcSEcCtD
Regorafenib—Neutropenia—Topiramate—migraine	0.000401	0.00335	CcSEcCtD
Regorafenib—Connective tissue disorder—Gabapentin—migraine	0.000401	0.00335	CcSEcCtD
Regorafenib—Urethral disorder—Gabapentin—migraine	0.0004	0.00334	CcSEcCtD
Regorafenib—Angiopathy—Timolol—migraine	0.000398	0.00332	CcSEcCtD
Regorafenib—KDR—nervous system—migraine	0.000398	0.00436	CbGeAlD
Regorafenib—Anaemia—Valproic Acid—migraine	0.000396	0.00331	CcSEcCtD
Regorafenib—Mediastinal disorder—Timolol—migraine	0.000395	0.0033	CcSEcCtD
Regorafenib—Nausea—Amitriptyline—migraine	0.000392	0.00327	CcSEcCtD
Regorafenib—Weight decreased—Topiramate—migraine	0.000388	0.00324	CcSEcCtD
Regorafenib—FGFR2—brain—migraine	0.000388	0.00425	CbGeAlD
Regorafenib—Alopecia—Timolol—migraine	0.000388	0.00324	CcSEcCtD
Regorafenib—Erythema multiforme—Gabapentin—migraine	0.000386	0.00322	CcSEcCtD
Regorafenib—Asthenia—Propranolol—migraine	0.000385	0.00321	CcSEcCtD
Regorafenib—Leukopenia—Valproic Acid—migraine	0.000384	0.0032	CcSEcCtD
Regorafenib—KDR—central nervous system—migraine	0.000383	0.00419	CbGeAlD
Regorafenib—Infestation NOS—Topiramate—migraine	0.000383	0.0032	CcSEcCtD
Regorafenib—Infestation—Topiramate—migraine	0.000383	0.0032	CcSEcCtD
Regorafenib—Malnutrition—Timolol—migraine	0.000382	0.00319	CcSEcCtD
Regorafenib—EPHA2—brain—migraine	0.000381	0.00418	CbGeAlD
Regorafenib—Stevens-Johnson syndrome—Topiramate—migraine	0.00038	0.00317	CcSEcCtD
Regorafenib—Cardiac disorder—Gabapentin—migraine	0.000379	0.00316	CcSEcCtD
Regorafenib—KDR—cerebellum—migraine	0.000374	0.0041	CbGeAlD
Regorafenib—Stomatitis—Topiramate—migraine	0.000373	0.00311	CcSEcCtD
Regorafenib—TEK—brain—migraine	0.000372	0.00407	CbGeAlD
Regorafenib—KIT—head—migraine	0.000372	0.00407	CbGeAlD
Regorafenib—Hypertension—Valproic Acid—migraine	0.00037	0.00309	CcSEcCtD
Regorafenib—Mediastinal disorder—Gabapentin—migraine	0.000368	0.00307	CcSEcCtD
Regorafenib—Diarrhoea—Propranolol—migraine	0.000367	0.00306	CcSEcCtD
Regorafenib—PDGFRB—head—migraine	0.000363	0.00398	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000363	0.00303	CcSEcCtD
Regorafenib—Alopecia—Gabapentin—migraine	0.000361	0.00301	CcSEcCtD
Regorafenib—FLT1—brain—migraine	0.00036	0.00394	CbGeAlD
Regorafenib—RAF1—brain—migraine	0.000358	0.00391	CbGeAlD
Regorafenib—Dry mouth—Valproic Acid—migraine	0.000357	0.00298	CcSEcCtD
Regorafenib—Malnutrition—Gabapentin—migraine	0.000356	0.00297	CcSEcCtD
Regorafenib—Asthenia—Verapamil—migraine	0.000354	0.00296	CcSEcCtD
Regorafenib—KIT—nervous system—migraine	0.000352	0.00386	CbGeAlD
Regorafenib—Infection—Valproic Acid—migraine	0.000348	0.0029	CcSEcCtD
Regorafenib—Haemoglobin—Topiramate—migraine	0.000345	0.00288	CcSEcCtD
Regorafenib—PDGFRB—nervous system—migraine	0.000344	0.00377	CbGeAlD
Regorafenib—Haemorrhage—Topiramate—migraine	0.000344	0.00287	CcSEcCtD
Regorafenib—Nervous system disorder—Valproic Acid—migraine	0.000343	0.00287	CcSEcCtD
Regorafenib—Thrombocytopenia—Valproic Acid—migraine	0.000343	0.00286	CcSEcCtD
Regorafenib—Vomiting—Propranolol—migraine	0.000341	0.00285	CcSEcCtD
Regorafenib—Skin disorder—Valproic Acid—migraine	0.00034	0.00284	CcSEcCtD
Regorafenib—Urinary tract disorder—Topiramate—migraine	0.000339	0.00283	CcSEcCtD
Regorafenib—KIT—central nervous system—migraine	0.000339	0.00372	CbGeAlD
Regorafenib—Rash—Propranolol—migraine	0.000338	0.00282	CcSEcCtD
Regorafenib—Dermatitis—Propranolol—migraine	0.000338	0.00282	CcSEcCtD
Regorafenib—Diarrhoea—Verapamil—migraine	0.000338	0.00282	CcSEcCtD
Regorafenib—Connective tissue disorder—Topiramate—migraine	0.000338	0.00282	CcSEcCtD
Regorafenib—PDGFRA—brain—migraine	0.000337	0.00369	CbGeAlD
Regorafenib—Urethral disorder—Topiramate—migraine	0.000337	0.00281	CcSEcCtD
Regorafenib—Tremor—Gabapentin—migraine	0.000333	0.00278	CcSEcCtD
Regorafenib—ABCB1—blood vessel—migraine	0.000333	0.00365	CbGeAlD
Regorafenib—KIT—cerebellum—migraine	0.000332	0.00363	CbGeAlD
Regorafenib—PDGFRB—central nervous system—migraine	0.000331	0.00363	CbGeAlD
Regorafenib—Hypertension—Timolol—migraine	0.00033	0.00275	CcSEcCtD
Regorafenib—Anaemia—Gabapentin—migraine	0.000329	0.00274	CcSEcCtD
Regorafenib—Erythema multiforme—Topiramate—migraine	0.000325	0.00271	CcSEcCtD
Regorafenib—PDGFRB—cerebellum—migraine	0.000324	0.00355	CbGeAlD
Regorafenib—ABL1—head—migraine	0.000324	0.00354	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000323	0.00269	CcSEcCtD
Regorafenib—Cardiac disorder—Topiramate—migraine	0.000319	0.00266	CcSEcCtD
Regorafenib—Nausea—Propranolol—migraine	0.000319	0.00266	CcSEcCtD
Regorafenib—Leukopenia—Gabapentin—migraine	0.000318	0.00266	CcSEcCtD
Regorafenib—Dry mouth—Timolol—migraine	0.000318	0.00265	CcSEcCtD
Regorafenib—Vomiting—Verapamil—migraine	0.000314	0.00262	CcSEcCtD
Regorafenib—Angiopathy—Topiramate—migraine	0.000312	0.0026	CcSEcCtD
Regorafenib—Rash—Verapamil—migraine	0.000311	0.0026	CcSEcCtD
Regorafenib—Dermatitis—Verapamil—migraine	0.000311	0.0026	CcSEcCtD
Regorafenib—Mediastinal disorder—Topiramate—migraine	0.00031	0.00258	CcSEcCtD
Regorafenib—Infection—Timolol—migraine	0.00031	0.00258	CcSEcCtD
Regorafenib—Headache—Verapamil—migraine	0.000309	0.00258	CcSEcCtD
Regorafenib—Hypertension—Gabapentin—migraine	0.000307	0.00256	CcSEcCtD
Regorafenib—ABL1—nervous system—migraine	0.000307	0.00336	CbGeAlD
Regorafenib—Nervous system disorder—Timolol—migraine	0.000306	0.00255	CcSEcCtD
Regorafenib—Decreased appetite—Valproic Acid—migraine	0.000304	0.00254	CcSEcCtD
Regorafenib—KDR—brain—migraine	0.000304	0.00333	CbGeAlD
Regorafenib—Alopecia—Topiramate—migraine	0.000304	0.00253	CcSEcCtD
Regorafenib—Skin disorder—Timolol—migraine	0.000303	0.00253	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Valproic Acid—migraine	0.000302	0.00252	CcSEcCtD
Regorafenib—Fatigue—Valproic Acid—migraine	0.000302	0.00252	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000301	0.00251	CcSEcCtD
Regorafenib—Pain—Valproic Acid—migraine	0.000299	0.0025	CcSEcCtD
Regorafenib—Malnutrition—Topiramate—migraine	0.000299	0.0025	CcSEcCtD
Regorafenib—Dry mouth—Gabapentin—migraine	0.000296	0.00247	CcSEcCtD
Regorafenib—ABL1—central nervous system—migraine	0.000295	0.00323	CbGeAlD
Regorafenib—Nausea—Verapamil—migraine	0.000293	0.00245	CcSEcCtD
Regorafenib—ABL1—cerebellum—migraine	0.000289	0.00316	CbGeAlD
Regorafenib—Infection—Gabapentin—migraine	0.000288	0.00241	CcSEcCtD
Regorafenib—Gastrointestinal pain—Valproic Acid—migraine	0.000286	0.00239	CcSEcCtD
Regorafenib—Nervous system disorder—Gabapentin—migraine	0.000285	0.00238	CcSEcCtD
Regorafenib—Thrombocytopenia—Gabapentin—migraine	0.000284	0.00237	CcSEcCtD
Regorafenib—Skin disorder—Gabapentin—migraine	0.000282	0.00235	CcSEcCtD
Regorafenib—Tremor—Topiramate—migraine	0.00028	0.00234	CcSEcCtD
Regorafenib—CYP2B6—cardiovascular system—migraine	0.000278	0.00304	CbGeAlD
Regorafenib—Abdominal pain—Valproic Acid—migraine	0.000277	0.00231	CcSEcCtD
Regorafenib—Body temperature increased—Valproic Acid—migraine	0.000277	0.00231	CcSEcCtD
Regorafenib—Anaemia—Topiramate—migraine	0.000277	0.00231	CcSEcCtD
Regorafenib—CYP2C9—cardiovascular system—migraine	0.000275	0.00301	CbGeAlD
Regorafenib—Decreased appetite—Timolol—migraine	0.000271	0.00226	CcSEcCtD
Regorafenib—KIT—brain—migraine	0.000269	0.00295	CbGeAlD
Regorafenib—Gastrointestinal disorder—Timolol—migraine	0.000269	0.00225	CcSEcCtD
Regorafenib—Fatigue—Timolol—migraine	0.000269	0.00224	CcSEcCtD
Regorafenib—Leukopenia—Topiramate—migraine	0.000268	0.00223	CcSEcCtD
Regorafenib—Pain—Timolol—migraine	0.000267	0.00222	CcSEcCtD
Regorafenib—PDGFRB—brain—migraine	0.000263	0.00288	CbGeAlD
Regorafenib—Hypertension—Topiramate—migraine	0.000258	0.00216	CcSEcCtD
Regorafenib—Gastrointestinal pain—Timolol—migraine	0.000255	0.00213	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000253	0.00211	CcSEcCtD
Regorafenib—Decreased appetite—Gabapentin—migraine	0.000252	0.00211	CcSEcCtD
Regorafenib—Asthenia—Valproic Acid—migraine	0.000251	0.0021	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Gabapentin—migraine	0.000251	0.00209	CcSEcCtD
Regorafenib—Fatigue—Gabapentin—migraine	0.00025	0.00209	CcSEcCtD
Regorafenib—Dry mouth—Topiramate—migraine	0.000249	0.00208	CcSEcCtD
Regorafenib—Pain—Gabapentin—migraine	0.000248	0.00207	CcSEcCtD
Regorafenib—Abdominal pain—Timolol—migraine	0.000246	0.00206	CcSEcCtD
Regorafenib—Body temperature increased—Timolol—migraine	0.000246	0.00206	CcSEcCtD
Regorafenib—Infection—Topiramate—migraine	0.000243	0.00202	CcSEcCtD
Regorafenib—Diarrhoea—Valproic Acid—migraine	0.00024	0.002	CcSEcCtD
Regorafenib—Nervous system disorder—Topiramate—migraine	0.000239	0.002	CcSEcCtD
Regorafenib—Thrombocytopenia—Topiramate—migraine	0.000239	0.002	CcSEcCtD
Regorafenib—Gastrointestinal pain—Gabapentin—migraine	0.000237	0.00198	CcSEcCtD
Regorafenib—Skin disorder—Topiramate—migraine	0.000237	0.00198	CcSEcCtD
Regorafenib—ABL1—brain—migraine	0.000235	0.00257	CbGeAlD
Regorafenib—Body temperature increased—Gabapentin—migraine	0.000229	0.00191	CcSEcCtD
Regorafenib—Abdominal pain—Gabapentin—migraine	0.000229	0.00191	CcSEcCtD
Regorafenib—Asthenia—Timolol—migraine	0.000224	0.00187	CcSEcCtD
Regorafenib—Vomiting—Valproic Acid—migraine	0.000223	0.00186	CcSEcCtD
Regorafenib—Rash—Valproic Acid—migraine	0.000221	0.00184	CcSEcCtD
Regorafenib—Dermatitis—Valproic Acid—migraine	0.000221	0.00184	CcSEcCtD
Regorafenib—Headache—Valproic Acid—migraine	0.000219	0.00183	CcSEcCtD
Regorafenib—Diarrhoea—Timolol—migraine	0.000213	0.00178	CcSEcCtD
Regorafenib—Decreased appetite—Topiramate—migraine	0.000212	0.00177	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Topiramate—migraine	0.000211	0.00176	CcSEcCtD
Regorafenib—Fatigue—Topiramate—migraine	0.000211	0.00176	CcSEcCtD
Regorafenib—Pain—Topiramate—migraine	0.000209	0.00174	CcSEcCtD
Regorafenib—Asthenia—Gabapentin—migraine	0.000208	0.00174	CcSEcCtD
Regorafenib—Nausea—Valproic Acid—migraine	0.000208	0.00174	CcSEcCtD
Regorafenib—ABCB1—trigeminal ganglion—migraine	0.000206	0.00225	CbGeAlD
Regorafenib—Gastrointestinal pain—Topiramate—migraine	0.0002	0.00167	CcSEcCtD
Regorafenib—Diarrhoea—Gabapentin—migraine	0.000199	0.00166	CcSEcCtD
Regorafenib—Vomiting—Timolol—migraine	0.000198	0.00165	CcSEcCtD
Regorafenib—Rash—Timolol—migraine	0.000196	0.00164	CcSEcCtD
Regorafenib—Dermatitis—Timolol—migraine	0.000196	0.00164	CcSEcCtD
Regorafenib—Headache—Timolol—migraine	0.000195	0.00163	CcSEcCtD
Regorafenib—Abdominal pain—Topiramate—migraine	0.000193	0.00161	CcSEcCtD
Regorafenib—Body temperature increased—Topiramate—migraine	0.000193	0.00161	CcSEcCtD
Regorafenib—CYP2B6—head—migraine	0.000188	0.00206	CbGeAlD
Regorafenib—Nausea—Timolol—migraine	0.000185	0.00154	CcSEcCtD
Regorafenib—Vomiting—Gabapentin—migraine	0.000185	0.00154	CcSEcCtD
Regorafenib—Rash—Gabapentin—migraine	0.000183	0.00153	CcSEcCtD
Regorafenib—Dermatitis—Gabapentin—migraine	0.000183	0.00153	CcSEcCtD
Regorafenib—ABCG2—cerebellum—migraine	0.000182	0.00199	CbGeAlD
Regorafenib—Headache—Gabapentin—migraine	0.000182	0.00152	CcSEcCtD
Regorafenib—CYP2B6—nervous system—migraine	0.000179	0.00195	CbGeAlD
Regorafenib—Asthenia—Topiramate—migraine	0.000175	0.00146	CcSEcCtD
Regorafenib—Nausea—Gabapentin—migraine	0.000172	0.00144	CcSEcCtD
Regorafenib—CYP2B6—central nervous system—migraine	0.000172	0.00188	CbGeAlD
Regorafenib—Diarrhoea—Topiramate—migraine	0.000167	0.00139	CcSEcCtD
Regorafenib—Vomiting—Topiramate—migraine	0.000155	0.0013	CcSEcCtD
Regorafenib—Rash—Topiramate—migraine	0.000154	0.00128	CcSEcCtD
Regorafenib—Dermatitis—Topiramate—migraine	0.000154	0.00128	CcSEcCtD
Regorafenib—Headache—Topiramate—migraine	0.000153	0.00128	CcSEcCtD
Regorafenib—CYP2C8—brain—migraine	0.000152	0.00167	CbGeAlD
Regorafenib—ABCB1—cardiovascular system—migraine	0.000149	0.00163	CbGeAlD
Regorafenib—ABCG2—brain—migraine	0.000148	0.00162	CbGeAlD
Regorafenib—Nausea—Topiramate—migraine	0.000145	0.00121	CcSEcCtD
Regorafenib—CYP2B6—brain—migraine	0.000136	0.00149	CbGeAlD
Regorafenib—CYP3A4—nervous system—migraine	0.000135	0.00148	CbGeAlD
Regorafenib—CYP3A4—central nervous system—migraine	0.00013	0.00142	CbGeAlD
Regorafenib—ABCB1—head—migraine	0.000101	0.0011	CbGeAlD
Regorafenib—ABCB1—nervous system—migraine	9.54e-05	0.00104	CbGeAlD
Regorafenib—ABCB1—central nervous system—migraine	9.19e-05	0.00101	CbGeAlD
Regorafenib—ABCB1—cerebellum—migraine	8.98e-05	0.000983	CbGeAlD
Regorafenib—ABCB1—brain—migraine	7.29e-05	0.000799	CbGeAlD
Regorafenib—KIT—Signaling Pathways—HTR1D—migraine	4.59e-05	0.000548	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—LRP1—migraine	4.58e-05	0.000547	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—PGR—migraine	4.5e-05	0.000537	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CACNA1A—migraine	4.47e-05	0.000534	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CACNA1A—migraine	4.47e-05	0.000534	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HTR7—migraine	4.39e-05	0.000524	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR1D—migraine	4.36e-05	0.00052	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR2B—migraine	4.35e-05	0.000519	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR1D—migraine	4.35e-05	0.000519	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	4.33e-05	0.000517	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR2B—migraine	4.27e-05	0.00051	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—NOTCH3—migraine	4.18e-05	0.000499	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—LRP1—migraine	4.17e-05	0.000498	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—migraine	4.16e-05	0.000497	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—migraine	4.15e-05	0.000496	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—TNF—migraine	4.15e-05	0.000495	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—LRP1—migraine	4.13e-05	0.000493	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—HTR2A—migraine	4.12e-05	0.000492	CbGpPWpGaD
Regorafenib—RAF1—Disease—LRP1—migraine	4.08e-05	0.000487	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR2B—migraine	4.05e-05	0.000484	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR2B—migraine	4.04e-05	0.000483	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NOTCH4—migraine	3.93e-05	0.00047	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR1D—migraine	3.91e-05	0.000468	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—LRP1—migraine	3.83e-05	0.000457	CbGpPWpGaD
Regorafenib—BRAF—Disease—CALCA—migraine	3.8e-05	0.000454	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CACNA1A—migraine	3.8e-05	0.000453	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR1B—migraine	3.8e-05	0.000453	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TGFBR2—migraine	3.78e-05	0.000452	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—LRP1—migraine	3.76e-05	0.000449	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—TNF—migraine	3.75e-05	0.000448	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—FOS—migraine	3.74e-05	0.000446	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NOTCH4—migraine	3.72e-05	0.000444	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—TNF—migraine	3.69e-05	0.000441	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—ESR1—migraine	3.66e-05	0.000437	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR1A—migraine	3.65e-05	0.000436	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—migraine	3.65e-05	0.000435	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR2B—migraine	3.64e-05	0.000435	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NPS—migraine	3.6e-05	0.00043	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TAC1—migraine	3.6e-05	0.00043	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PGR—migraine	3.6e-05	0.00043	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR1B—migraine	3.59e-05	0.000428	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR1B—migraine	3.58e-05	0.000427	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—LRP1—migraine	3.57e-05	0.000426	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—LRP1—migraine	3.56e-05	0.000425	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR2C—migraine	3.53e-05	0.000422	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CALCA—migraine	3.52e-05	0.000421	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR1D—migraine	3.49e-05	0.000417	CbGpPWpGaD
Regorafenib—KIT—Disease—CALCA—migraine	3.46e-05	0.000413	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR1A—migraine	3.45e-05	0.000412	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR1A—migraine	3.44e-05	0.000411	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—EDNRA—migraine	3.43e-05	0.00041	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—FOS—migraine	3.43e-05	0.00041	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PGR—migraine	3.4e-05	0.000406	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NPS—migraine	3.4e-05	0.000406	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TAC1—migraine	3.4e-05	0.000406	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—NPS—migraine	3.39e-05	0.000405	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—TAC1—migraine	3.39e-05	0.000405	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—FOS—migraine	3.37e-05	0.000402	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NOTCH3—migraine	3.35e-05	0.0004	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR2C—migraine	3.33e-05	0.000398	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—migraine	3.33e-05	0.000398	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR2C—migraine	3.33e-05	0.000397	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CALCA—migraine	3.3e-05	0.000395	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CALCA—migraine	3.28e-05	0.000392	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CALCA—migraine	3.27e-05	0.000391	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.25e-05	0.000388	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR2B—migraine	3.24e-05	0.000387	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—EDNRA—migraine	3.24e-05	0.000387	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—EDNRA—migraine	3.24e-05	0.000387	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—LRP1—migraine	3.2e-05	0.000383	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—FOS—migraine	3.2e-05	0.000382	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NOTCH4—migraine	3.2e-05	0.000382	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—FOS—migraine	3.19e-05	0.000381	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—TNF—migraine	3.19e-05	0.000381	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NOTCH4—migraine	3.17e-05	0.000378	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NOTCH3—migraine	3.16e-05	0.000378	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CALCA—migraine	3.12e-05	0.000373	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CALCA—migraine	3.12e-05	0.000372	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR7—migraine	3.09e-05	0.000369	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR1B—migraine	3.08e-05	0.000368	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HTR2A—migraine	3.07e-05	0.000367	CbGpPWpGaD
Regorafenib—BRAF—Disease—TGFBR2—migraine	3.06e-05	0.000365	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR1B—migraine	3.06e-05	0.000365	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR1A—migraine	2.97e-05	0.000355	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CALCA—migraine	2.95e-05	0.000352	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR1A—migraine	2.94e-05	0.000351	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NOTCH4—migraine	2.94e-05	0.000351	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PGR—migraine	2.92e-05	0.000349	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TAC1—migraine	2.92e-05	0.000349	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NPS—migraine	2.92e-05	0.000349	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR7—migraine	2.92e-05	0.000349	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR7—migraine	2.91e-05	0.000348	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NPS—migraine	2.9e-05	0.000346	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PGR—migraine	2.9e-05	0.000346	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TAC1—migraine	2.9e-05	0.000346	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NOTCH4—migraine	2.88e-05	0.000344	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—FOS—migraine	2.87e-05	0.000343	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR2C—migraine	2.87e-05	0.000343	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—LRP1—migraine	2.86e-05	0.000341	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR2C—migraine	2.84e-05	0.000339	CbGpPWpGaD
Regorafenib—FGFR2—Disease—TGFBR2—migraine	2.84e-05	0.000339	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR1B—migraine	2.83e-05	0.000338	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—FOS—migraine	2.8e-05	0.000334	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—EDNRA—migraine	2.79e-05	0.000333	CbGpPWpGaD
Regorafenib—KIT—Disease—TGFBR2—migraine	2.78e-05	0.000333	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CACNA1A—migraine	2.78e-05	0.000332	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR1B—migraine	2.78e-05	0.000332	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—EDNRA—migraine	2.76e-05	0.00033	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NOTCH4—migraine	2.74e-05	0.000327	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NOTCH4—migraine	2.73e-05	0.000326	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—ESR1—migraine	2.73e-05	0.000326	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR1A—migraine	2.73e-05	0.000326	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NOTCH3—migraine	2.72e-05	0.000325	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NOTCH3—migraine	2.69e-05	0.000322	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CALCA—migraine	2.69e-05	0.000321	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TAC1—migraine	2.68e-05	0.000321	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NPS—migraine	2.68e-05	0.000321	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PGR—migraine	2.68e-05	0.000321	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR1A—migraine	2.68e-05	0.00032	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TGFBR2—migraine	2.66e-05	0.000318	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CALCA—migraine	2.66e-05	0.000318	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—TNF—migraine	2.65e-05	0.000316	CbGpPWpGaD
Regorafenib—FGFR1—Disease—TGFBR2—migraine	2.64e-05	0.000316	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR1B—migraine	2.64e-05	0.000315	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PGR—migraine	2.64e-05	0.000315	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NPS—migraine	2.64e-05	0.000315	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TAC1—migraine	2.64e-05	0.000315	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—TGFBR2—migraine	2.64e-05	0.000315	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR2C—migraine	2.63e-05	0.000314	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR1B—migraine	2.63e-05	0.000314	CbGpPWpGaD
Regorafenib—RAF1—Disease—CALCA—migraine	2.63e-05	0.000314	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR2C—migraine	2.59e-05	0.000309	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—EDNRA—migraine	2.56e-05	0.000306	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—FOS—migraine	2.56e-05	0.000306	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR1A—migraine	2.54e-05	0.000304	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR1A—migraine	2.53e-05	0.000303	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—EDNRA—migraine	2.52e-05	0.0003	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TGFBR2—migraine	2.52e-05	0.0003	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR7—migraine	2.51e-05	0.0003	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NPS—migraine	2.5e-05	0.000299	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TAC1—migraine	2.5e-05	0.000299	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PGR—migraine	2.5e-05	0.000299	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NPS—migraine	2.5e-05	0.000298	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TAC1—migraine	2.5e-05	0.000298	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NOTCH3—migraine	2.5e-05	0.000298	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PGR—migraine	2.5e-05	0.000298	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR7—migraine	2.49e-05	0.000297	CbGpPWpGaD
Regorafenib—BRAF—Disease—MTHFR—migraine	2.48e-05	0.000297	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CALCA—migraine	2.47e-05	0.000294	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NOTCH4—migraine	2.46e-05	0.000294	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR2C—migraine	2.45e-05	0.000293	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NOTCH3—migraine	2.45e-05	0.000293	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR2C—migraine	2.45e-05	0.000292	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CALCA—migraine	2.42e-05	0.000289	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—ESR1—migraine	2.4e-05	0.000287	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—EDNRA—migraine	2.39e-05	0.000285	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—EDNRA—migraine	2.38e-05	0.000284	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—TGFBR2—migraine	2.38e-05	0.000284	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR1B—migraine	2.37e-05	0.000283	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CACNA1A—migraine	2.36e-05	0.000281	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NOTCH3—migraine	2.33e-05	0.000278	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NOTCH3—migraine	2.32e-05	0.000277	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR7—migraine	2.31e-05	0.000275	CbGpPWpGaD
Regorafenib—FGFR2—Disease—MTHFR—migraine	2.3e-05	0.000275	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CALCA—migraine	2.3e-05	0.000274	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CALCA—migraine	2.29e-05	0.000274	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR1A—migraine	2.28e-05	0.000273	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—TNF—migraine	2.27e-05	0.000272	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR7—migraine	2.26e-05	0.000271	CbGpPWpGaD
Regorafenib—KIT—Disease—MTHFR—migraine	2.26e-05	0.00027	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NPS—migraine	2.25e-05	0.000269	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TAC1—migraine	2.25e-05	0.000269	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PGR—migraine	2.25e-05	0.000269	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR2C—migraine	2.2e-05	0.000263	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NOTCH4—migraine	2.19e-05	0.000262	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—FOS—migraine	2.18e-05	0.00026	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR2A—migraine	2.16e-05	0.000259	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TGFBR2—migraine	2.16e-05	0.000258	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR7—migraine	2.15e-05	0.000257	CbGpPWpGaD
Regorafenib—FGFR1—Disease—MTHFR—migraine	2.15e-05	0.000256	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—EDNRA—migraine	2.14e-05	0.000256	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR7—migraine	2.14e-05	0.000256	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TGFBR2—migraine	2.14e-05	0.000256	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—MTHFR—migraine	2.14e-05	0.000256	CbGpPWpGaD
Regorafenib—RAF1—Disease—TGFBR2—migraine	2.12e-05	0.000253	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR1B—migraine	2.11e-05	0.000253	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CACNA1A—migraine	2.1e-05	0.000251	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NOTCH3—migraine	2.09e-05	0.00025	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CALCA—migraine	2.06e-05	0.000247	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CACNA1A—migraine	2.05e-05	0.000245	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR2A—migraine	2.05e-05	0.000244	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR2A—migraine	2.04e-05	0.000244	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR1A—migraine	2.03e-05	0.000243	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NPS—migraine	2e-05	0.000239	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TAC1—migraine	2e-05	0.000239	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PGR—migraine	2e-05	0.000239	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—FOS—migraine	2e-05	0.000239	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TGFBR2—migraine	1.99e-05	0.000237	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR2C—migraine	1.97e-05	0.000235	CbGpPWpGaD
Regorafenib—KIT—Immune System—FOS—migraine	1.96e-05	0.000234	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TGFBR2—migraine	1.95e-05	0.000233	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TNF—migraine	1.95e-05	0.000233	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR7—migraine	1.93e-05	0.000231	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—MTHFR—migraine	1.93e-05	0.00023	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—ESR1—migraine	1.92e-05	0.00023	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CACNA1A—migraine	1.92e-05	0.000229	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—EDNRA—migraine	1.91e-05	0.000228	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NOTCH3—migraine	1.86e-05	0.000223	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—FOS—migraine	1.86e-05	0.000222	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—FOS—migraine	1.86e-05	0.000222	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TGFBR2—migraine	1.85e-05	0.000221	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TGFBR2—migraine	1.85e-05	0.000221	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CALCA—migraine	1.84e-05	0.00022	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—ESR1—migraine	1.82e-05	0.000217	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR2A—migraine	1.76e-05	0.00021	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR2A—migraine	1.74e-05	0.000208	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR7—migraine	1.72e-05	0.000206	CbGpPWpGaD
Regorafenib—RAF1—Disease—MTHFR—migraine	1.72e-05	0.000205	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TNF—migraine	1.7e-05	0.000204	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—FOS—migraine	1.67e-05	0.0002	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TGFBR2—migraine	1.66e-05	0.000199	CbGpPWpGaD
Regorafenib—ABL1—Immune System—FOS—migraine	1.63e-05	0.000195	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR2A—migraine	1.61e-05	0.000193	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR2A—migraine	1.59e-05	0.000189	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.57e-05	0.000188	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—ESR1—migraine	1.56e-05	0.000187	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TNF—migraine	1.56e-05	0.000186	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—ESR1—migraine	1.55e-05	0.000185	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR2A—migraine	1.51e-05	0.00018	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR2A—migraine	1.5e-05	0.000179	CbGpPWpGaD
Regorafenib—RAF1—Immune System—FOS—migraine	1.49e-05	0.000178	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TGFBR2—migraine	1.48e-05	0.000177	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—MTHFR—migraine	1.48e-05	0.000177	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—MTHFR—migraine	1.48e-05	0.000177	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—ESR1—migraine	1.43e-05	0.000171	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—ESR1—migraine	1.41e-05	0.000168	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR2A—migraine	1.35e-05	0.000162	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—ESR1—migraine	1.34e-05	0.00016	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—ESR1—migraine	1.33e-05	0.000159	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CACNA1A—migraine	1.26e-05	0.000151	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—MTHFR—migraine	1.26e-05	0.00015	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR2A—migraine	1.21e-05	0.000144	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—ESR1—migraine	1.2e-05	0.000143	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ESR1—migraine	1.07e-05	0.000128	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MTHFR—migraine	9.21e-06	0.00011	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MTHFR—migraine	7.79e-06	9.31e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MTHFR—migraine	6.96e-06	8.31e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MTHFR—migraine	6.79e-06	8.11e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MTHFR—migraine	6.34e-06	7.58e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MTHFR—migraine	4.18e-06	5e-05	CbGpPWpGaD
